This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_NASAL_CAVITY_MIDDLE_EAR_EXALLC for full statistics.
Malignant neoplasm of nasal cavity and middle ear
C3_NASAL_CAVITY_MIDDLE_EAR
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
154 |
4. Check minimum number of eventsNone |
154 |
5. Include endpointsNone |
154 |
6. Filter based on genotype QC (FinnGen only) |
154 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of nasal cavity and middle ear
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of nasal cavity and sinuses
- Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 154 | 63 | 91 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.04 |
| Median age at first event (years) | 66.01 | 64.50 | 67.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 139
- Matched controls
- 1392
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
121.2
98
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
128.2
53.7
55
7
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
45.3
41
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
116.8
45.3
47
6
UDH02
NOMESCO Finland
Rhinopharyngoscopy
22.3
42.7
66
54
DHB10
NOMESCO Finland
Excision of lesion of internal nose
103.4
36.0
38
5
WF003
NOMESCO Finland
Adjuvant radiotherapy
25.9
29.2
41
22
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
+∞
23.6
22
*
8720/3-C30.0
ICD-O-3
Malignant melanoma, NOS, of nasal cavity
+∞
23.6
22
*
130
Kela drug reimbursment
Malignant tumour
12.4
23.2
44
50
UDM02
NOMESCO Finland
Sinoscopy
34.6
22.0
28
10
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
20.3
19
*
R04.0
ICD-10 Finland
Epistaxis
8.8
18.0
41
63
WF002
NOMESCO Finland
Radical radiotherapy
10.5
17.4
35
43
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
32.3
17.1
22
8
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
17.0
16
*
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
+∞
17.0
16
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.5
16.9
43
78
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.8
16.7
78
292
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
14.3
16.5
28
24
A03FA01
ATC
metoclopramide; systemic, rectal
5.2
15.5
57
163
H02AB02
ATC
dexamethasone; systemic
7.5
14.9
37
64
DPA30
NOMESCO Finland
Sphenotomy
+∞
14.8
14
*
A04AA01
ATC
ondansetron; systemic, rectal
11.0
14.6
28
31
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
48.0
14.5
17
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
34.1
14.3
18
6
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
15.0
14.0
23
18
C72.2
ICD-10 Finland
Malignant neoplasm: Olfactory nerve
+∞
13.8
13
*
9522/3-C30.0
ICD-O-3
Olfactory neuroblastoma of nasal cavity
+∞
13.8
13
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
15.1
13.5
22
17
EP1AE
NOMESCO Finland
Neck ultrasound examination
10.8
13.5
26
29
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
25.6
13.3
18
8
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
55.6
13.1
15
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
12.7
12
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
16.7
12.2
19
13
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.3
12.0
25
32
UDQ12
NOMESCO Finland
Flexible laryngoscopy
9.0
11.8
25
33
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
11.6
11
*
DPC35
NOMESCO Finland
Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus
+∞
11.6
11
*
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
11.6
11
*
DHB40
NOMESCO Finland
Conchotomy
130.4
11.6
12
*
SAA03
NOMESCO Finland
Extended examination of mouth
3.7
11.6
70
301
A04AA02
ATC
granisetron; systemic, transdermal
7.7
11.5
27
42
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
8.6
11.1
24
33
ZXC95
NOMESCO Finland
Use of surgical navigator
118.6
10.6
11
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
10.5
10
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
20.8
10.5
15
8
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.8
10.4
22
29
N02AA05
ATC
oxycodone; systemic
4.3
10.4
42
126
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.3
10.3
73
345
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
7.2
10.3
25
41
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
43.5
10.1
12
*
L03AA02
ATC
filgrastim; parenteral
18.5
10.1
15
9
A07AA02
ATC
nystatin; oral
7.7
9.9
23
35
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
5.6
9.8
29
62
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
32.6
9.6
12
*
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
107.0
9.5
10
*
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
9.5
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
10.2
9.4
18
20
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
53.4
8.8
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
21.7
8.6
12
6
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
8.4
8
*
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
+∞
8.4
8
*
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
8.4
8
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
9.1
8.4
17
21
WX402
NOMESCO Finland
General anaesthesia
3.9
8.3
36
113
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.5
8.2
21
37
WF049
NOMESCO Finland
Radiotherapy of metastasis
10.4
8.0
15
16
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
16.3
7.9
12
8
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
26.7
7.7
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
7.5
55
254
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
84.4
7.5
8
*
DLW99
NOMESCO Finland
Other plastic operations on nose
84.4
7.5
8
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
16.9
7.4
11
7
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
7.4
7
*
L01CB01
ATC
etoposide; systemic
+∞
7.4
7
*
DHB01
NOMESCO Finland
Partial excision of external nose
+∞
7.4
7
*
Z51.5
ICD-10 Finland
Palliative care
5.2
7.3
22
48
SAA04
NOMESCO Finland
Special inverstigation of mouth
9.6
7.2
14
16
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
21.4
7.2
10
5
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
31.8
7.2
9
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
9.0
7.0
14
17
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.2
6.6
25
69
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.6
6.6
75
436
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
15.3
6.5
10
7
R4190
NOMESCO Finland
Nutritional therapy
8.8
6.5
13
16
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
11.8
6.4
11
10
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
28.1
6.3
8
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
28.1
6.3
8
*
8200/3-C30.0
ICD-O-3
Adenoid cystic carcinoma of nasal cavity
+∞
6.3
6
*
DKW99
NOMESCO Finland
Other procedures for control of epistaxis
+∞
6.3
6
*
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
+∞
6.3
6
*
8020/3-C30.0
ICD-O-3
Carcinoma, undifferentiated, NOS, of nasal cavity
+∞
6.3
6
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
+∞
6.3
6
*
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
+∞
6.3
6
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
8.3
6.3
13
17
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.7
6.3
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
63
127
7.70
33.04
1.8
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
53
140
5.25
19.84
2.2
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
19
8
26.83
14.18
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
53
187
3.80
12.98
2.2
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
92
485
3.23
11.48
3.9
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
12
10.76
10.57
1.6
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
104
628
3.02
9.54
7.0
6.5
mmol/l
1.2
1.2
0.49
86
535
(3008295) Osmolality of Serum or Plasma
12
15
8.59
8.99
1.2
1.1
mosm/kgh2o
287.7
276.6
—
12
9
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
94
568
2.68
8.10
6.7
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
107
709
2.67
7.34
15.4
9.9
e9/l
3.9
4.1
0.43
96
623
(3002256) Pathology report gross observation
36
145
2.94
6.73
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
29
110
3.02
5.99
1.4
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
69
406
2.27
5.72
8.0
5.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
105
2.91
5.32
1.5
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
67
400
2.19
5.27
2.7
2.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
7
11.96
4.84
1.9
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
52
292
2.18
4.67
1.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
90
622
2.08
4.65
6.7
5.9
e9/l
0.2
0.2
0.72
78
550
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
11
8.60
4.63
1.2
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
60
363
2.07
4.40
5.2
4.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
61
377
2.02
4.18
5.5
4.1
ph
7.4
7.4
0.03
16
72
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
139
2.44
4.17
2.0
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
140
2.42
4.11
1.6
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
32
154
2.36
4.10
5.9
6.3
mmol/l
0.8
1.0
0.08
23
122
(3000494) Fungus identified in Specimen by Culture
32
158
2.29
3.86
1.5
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
34
3.74
3.85
1.2
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
29
138
2.36
3.80
2.0
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
85
606
1.90
3.72
6.5
5.6
e9/l
0.6
0.6
0.35
71
527
(3006315) Basophils [#/volume] in Blood
85
607
1.89
3.69
6.5
5.6
e9/l
0.0
0.0
1.12
71
530
(3019198) Lymphocytes [#/volume] in Blood
86
617
1.89
3.67
6.6
5.7
e9/l
2.0
1.7
0.22
73
551
(3016018) Differential panel - Cerebral spinal fluid
7
9
8.08
3.59
2.1
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
89
2.57
3.50
1.3
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
42
3.29
3.46
1.9
2.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
27
3.89
3.41
1.3
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
52
324
1.91
3.37
10.4
6.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
61
401
1.86
3.35
2.9
3.3
e6/l
34.0
223.2
0.62
46
311
(3018095) Leukocytes [#/volume] in Urine
66
448
1.83
3.25
3.2
3.9
e6/l
11.1
59.5
3.45
47
331
(40768795) Lymph node Pathology biopsy report
7
11
6.60
3.22
1.3
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
19
80
2.57
3.21
1.6
2.4
g/l
10.1
9.8
0.10
19
73
(3000850) Epithelial cells [#/volume] in Urine
45
271
1.93
3.21
2.5
2.9
e6/l
6.4
4.7
0.41
40
239
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
16
5.21
3.09
2.1
1.7
ug/l
13.3
18.6
—
8
16
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
8
7.74
3.08
1.8
2.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
299
1.88
3.08
2.2
2.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
21
4.48
3.04
1.1
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
17
4.90
2.96
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
106
846
1.81
2.91
4.1
4.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
9
6.88
2.89
2.3
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
9
6.88
2.89
2.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
72
2.53
2.84
1.5
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
18
4.63
2.83
2.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
23
4.09
2.82
1.2
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
6
8.56
2.77
2.4
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
74
542
1.70
2.68
11.8
10.2
e9/l
0.0
0.0
0.12
60
441
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
98
1159
0.58
2.64
3.8
4.9
mmol/l
1.4
1.4
0.43
90
1056
(3026389) Candida sp identified in Specimen by Organism specific culture
7
15
4.83
2.63
1.9
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
195
1.88
2.45
2.2
1.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
22
3.78
2.40
1.3
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
92
2.22
2.39
4.4
2.7
ml/min/173m2
64.6
59.9
—
8
36
(3030467) Casts [#/volume] in Urine by Automated count
53
364
1.70
2.38
2.6
3.1
e6/l
0.2
0.5
1.60
37
274
(3019060) Gas panel - Arterial blood
18
88
2.18
2.22
5.1
4.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
24
132
1.97
2.19
5.7
3.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
64
470
1.62
2.19
2.8
3.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
30
3.12
2.18
1.4
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
14
4.41
2.17
1.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
49
338
1.66
2.13
2.6
3.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
97
1129
0.62
2.08
3.6
4.3
mmol/l
1.4
1.3
0.57
87
1024
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
18
92
2.08
2.00
2.9
2.6
ng/l
113.0
168.9
0.72
18
81
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
21
3.44
1.99
1.1
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
7
22
3.28
1.90
1.0
1.5
mmol/l
78.1
62.3
—
7
22
(3021440) Promyelocytes/100 leukocytes in Blood
18
94
2.04
1.89
4.8
5.2
%
0.2
0.1
0.17
11
33
(3002179) Metamyelocytes/100 leukocytes in Blood
17
87
2.07
1.88
4.6
5.0
%
2.0
0.3
—
7
24
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
102
1164
0.63
1.84
3.9
4.9
mmol/l
4.6
4.5
0.31
95
1068
(3017181) Myelocytes/100 leukocytes in Blood
19
104
1.94
1.77
4.6
4.9
%
2.1
1.1
—
10
38
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
12
232
0.48
1.70
1.2
1.2
u/ml
9.4
1.8
—
5
59
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
19
3.24
1.68
5.3
2.2
e9/l
4.3
4.7
—
6
19
(40760892) CBC W Ordered Manual Differential panel - Blood
38
262
1.60
1.63
4.3
5.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
20
3.08
1.59
7.7
3.2
%
68.3
57.6
—
6
20
(3020682) Albumin/Creatinine [Ratio] in Urine
28
410
0.61
1.54
3.9
4.1
mg/mmol
8.7
8.2
0.02
17
269
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
15
3.41
1.53
1.0
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
5
15
3.41
1.53
6.2
2.5
—
53.0
—
0
8
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
15
3.41
1.53
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
115
1011
1.54
1.53
22.8
16.2
%
37.1
39.9
2.11
83
678
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
37
2.52
1.50
1.9
1.6
—
—
—
0
0
(3013512) EKG study
28
407
0.62
1.49
3.9
4.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
107
1193
0.66
1.49
4.1
5.4
mmol/l
2.7
2.7
0.06
97
1082
(3032080) INR in Blood by Coagulation assay
68
543
1.45
1.45
6.6
8.0
inr
1.2
1.3
0.08
21
155
(1761868) Lipid panel - Serum or Plasma
27
391
0.62
1.40
3.3
3.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
18
2.83
1.29
1.8
2.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
6
25
2.45
1.25
1.2
1.8
—
3.5
—
0
10
(40760888) Immunoglobulin light chains.free panel - Serum
6
25
2.45
1.25
7.3
6.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
19
2.68
1.22
1.0
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
45
342
1.45
1.22
4.4
3.0
umol/l
323.2
8415.0
1.98
40
282
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
20
2.55
1.16
1.2
3.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
8
40
2.05
1.14
6.5
4.7
mg/l
70.9
29.4
—
8
33
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
66
1.89
1.12
9.4
8.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
128
1179
1.51
1.09
26.3
15.4
mg/l
25.5
23.8
0.30
115
969
(3002032) Base excess in Venous blood by calculation
19
122
1.64
1.09
2.5
4.0
mmol/l
3.0
2.0
0.89
19
83
(3026782) Osmolality of Urine
35
259
1.45
1.08
2.6
3.1
mosm/kgh2o
550.4
578.9
0.33
30
221
(3012516) Albumin [Mass/volume] in Urine
28
382
0.67
1.08
3.6
3.3
mg/l
3885.0
214.6
0.74
21
255
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
22
2.31
1.04
2.8
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
22
2.31
1.04
2.8
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
93
815
1.36
1.04
4.1
4.4
e6/l
391.9
521.1
—
7
17
(3025159) Blasts/100 leukocytes in Blood
15
92
1.70
1.01
5.3
5.2
%
0.0
0.3
—
8
29
(3012544) pH of Venous blood
20
133
1.58
1.00
2.6
3.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
23
2.21
0.99
1.8
2.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
31
0.00
0.97
0.0
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
62
1.83
0.97
1.9
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
19
126
1.58
0.97
2.5
3.9
kpa
6.1
5.7
1.15
19
118
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
42
521
0.73
0.92
2.0
2.0
pmol/l
86.6
92.0
0.40
23
260
(3000991) Gas panel - Venous blood
17
111
1.60
0.92
5.7
7.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
29
2.11
0.90
1.7
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
116
1066
1.36
0.86
4.8
4.6
mu/l
2.2
2.0
0.56
110
949
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
32
1.91
0.82
1.2
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
24
2.12
0.75
1.8
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
9
55
1.68
0.75
1.1
1.8
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
7
40
1.78
0.72
7.3
4.7
mg/l
24.1
238.8
—
7
33
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
10
61
1.68
0.70
3.0
4.5
mmol/l
26.9
24.1
—
10
51
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
120
1126
1.30
0.63
24.0
14.7
ml/min/173m2
82.7
77.7
2.18
104
919
(3028026) IgM [Mass/volume] in Serum or Plasma
10
63
1.63
0.63
1.3
1.6
g/l
1.0
1.2
—
10
57
(40761535) Cells panel - Urine sediment
15
105
1.47
0.63
1.7
3.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
30
1.69
0.62
1.2
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
110
1170
0.79
0.60
4.5
5.0
mmol/l
6.1
6.1
0.05
100
1061
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
21
0.00
0.60
0.0
4.1
—
34.9
—
0
7
(3016879) Cocaine [Presence] in Urine
0
22
0.00
0.60
0.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
(3020891) Body temperature
8
55
1.48
0.57
2.1
4.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
61
1.50
0.55
5.9
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
65
1.41
0.51
1.4
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
40
341
1.23
0.49
3.0
3.9
estimate
0.0
0.0
0.00
14
111
(3020564) Creatinine [Moles/volume] in Serum or Plasma
132
1266
1.30
0.49
30.0
18.3
umol/l
75.0
81.9
3.15
132
1266
(3037467) Urinalysis macro (dipstick) panel - Urine
91
844
1.19
0.46
3.8
4.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
150
0.71
0.44
1.4
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
31
1.63
0.43
1.6
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
31
1.63
0.43
1.0
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
8
57
1.43
0.43
3.4
2.1
ug/l
0.6
6.4
—
8
51
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
17
0.00
0.41
0.0
4.0
—
83.2
—
0
17
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
2.7
—
54.8
—
0
18
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
108
1134
0.84
0.40
5.2
6.5
mmol/mol
40.7
40.8
0.03
99
1047
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
37.7
—
0
6
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
72
1.42
0.38
1.7
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
43
1.41
0.35
1.2
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
7
52
1.36
0.31
7.1
2.1
g/l
40.7
38.1
—
7
45
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
7
53
1.34
0.31
7.7
2.1
g/l
0.5
0.5
—
7
48
(3004588) Protein electrophoresis panel - Serum or Plasma
12
93
1.31
0.31
5.0
2.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
18
214
0.82
0.28
1.9
2.3
umol/l
18.5
13.0
0.44
18
186
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
73
0.67
0.26
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
75
0.66
0.26
1.6
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
38
342
1.15
0.26
3.4
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
64
598
1.12
0.25
3.0
3.8
estimate
0.0
0.0
0.00
15
116
(3010813) Leukocytes [#/volume] in Blood
134
1308
1.19
0.25
33.8
22.6
e9/l
7.1
6.7
0.57
128
1269
(3026361) Erythrocytes [#/volume] in Blood
134
1308
1.19
0.25
33.8
22.5
e12/l
4.2
4.5
6.85
129
1269
(3000963) Hemoglobin [Mass/volume] in Blood
134
1308
1.19
0.25
34.0
22.7
g/l
126.1
135.6
8.86
134
1288
(3020630) Protein [Mass/volume] in Serum or Plasma
13
106
1.25
0.24
4.9
2.5
g/l
63.9
66.5
0.67
13
96
(3052851) Hemolysis interference index of Serum or Plasma
5
38
1.33
0.23
3.2
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
38
1.33
0.23
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
40
1.26
0.22
1.6
1.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
19.2
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
10
0.00
0.21
0.0
2.6
—
4.3
—
0
10
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
52
556
0.90
0.20
3.6
3.9
ng/l
1207.9
47.2
0.49
38
401
(3011288) Drugs identified in Urine by Screen method
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
12
99
1.23
0.20
4.2
3.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
164
0.84
0.19
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
59
1.20
0.18
1.4
2.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
31
283
1.12
0.17
1.6
1.8
mg/l
2.8
1.3
1.00
26
224
(3017732) Neutrophils [#/volume] in Blood
10
82
1.23
0.17
2.5
2.6
e9/l
4.4
3.6
—
10
60
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
51
481
1.09
0.16
3.2
4.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
80
1.13
0.15
2.0
2.8
—
—
—
0
0
(3009343) pH of Capillary blood
7
85
0.82
0.15
2.6
3.8
—
7.4
—
0
11
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
61
639
0.92
0.15
2.7
2.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
202
1.10
0.11
2.8
2.8
e6/l
0.0
1.7
—
10
117
(3019225) pH of Specimen
11
125
0.87
0.10
4.8
4.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
18
197
0.90
0.10
1.7
2.3
g/l
2.3
2.3
0.11
18
172
(1761482) Bacteria [#/volume] in Urine by Culture
5
46
1.09
0.09
3.4
4.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
126
1.12
0.09
1.4
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
125
1233
1.07
0.08
21.4
14.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
58
1.04
0.08
1.8
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
62
0.80
0.08
1.8
3.9
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
68
1.03
0.08
1.7
2.7
%
0.7
1.3
—
7
68
(3009261) Glucose [Presence] in Urine by Test strip
63
612
1.05
0.07
3.2
3.9
estimate
0.0
0.0
0.00
14
108
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
8
78
1.03
0.07
2.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
44
455
0.95
0.06
4.7
4.4
%
23.3
22.0
0.18
26
231
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
168
1.08
0.06
12.3
7.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
62
605
1.04
0.05
4.2
5.2
estimate
0.0
0.0
0.00
15
119
(3019309) Folate [Moles/volume] in Red Blood Cells
25
261
0.95
0.04
1.4
1.6
nmol/l
1098.0
1208.4
0.30
20
186
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
47
478
0.98
0.01
2.0
2.4
nmol/l
69.9
76.1
0.97
42
412
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
15
157
0.95
0.01
1.1
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
11
109
1.01
0.00
2.3
2.9
kpa
4.8
4.3
0.24
11
100
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
216
1.02
0.00
2.7
2.6
e6/l
0.4
0.9
—
10
130
(3011397) Hemoglobin [Presence] in Urine by Test strip
26
264
0.98
0.00
2.1
3.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
38
376
1.01
0.00
2.8
3.2
—
—
—
0
0
(3000492) Spirometry study
11
107
1.03
0.00
1.4
1.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
6
0.00
0.00
0.0
2.2
—
17.6
—
0
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
29.7
—
0
6
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
24.3
—
0
6
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
9.6
—
0
9
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
1068.0
—
0
7
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(44813793)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4010399)
8
89
0.89
0.00
1.3
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
72.0
—
0
5
(3020491) Glucose [Moles/volume] in Blood
0
7
0.00
0.00
0.0
2.6
—
6.9
—
0
7
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
9.8
—
0
7
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4062490)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
148.0
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
7.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
66
0.91
0.00
3.3
4.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
6
59
1.02
0.00
1.3
1.3
u/ml
236.8
235.8
—
6
53
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
7.0
—
913.8
—
0
5
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
21.2
—
1222.2
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
53
0.94
0.00
1.6
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NASAL_CAVITY_MIDDLE_EAR – Malignant neoplasm of nasal cavity and middle ear
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).